Cargando…

Prognostic Significance of High Expression of ER-beta in Surgically Treated ER-Positive Breast Cancer Following Endocrine Therapy

PURPOSE: This study evaluated estrogen receptor (ER)-beta mRNA and ER-beta protein expression and its prognostic implications in hormone receptor-positive breast cancer. METHODS: Paraffin sections from 139 hormone receptor-positive breast cancer cases were prepared. The expression of ER-beta mRNA an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Tae-Jung, Lee, Ahwon, Choi, Yeong-Jin, Song, Byung Joo, Yim, Hyeon Woo, Kang, Chang Suk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Breast Cancer Society 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3318179/ https://www.ncbi.nlm.nih.gov/pubmed/22493632 http://dx.doi.org/10.4048/jbc.2012.15.1.79

Ejemplares similares

An estrogen receptor (ER)‐related signature in predicting prognosis of ER‐positive breast cancer following endocrine treatment
por: Tang, Jianing, et al.
Publicado: (2019)

ECM1 is associated with endocrine resistance in ER(+) breast cancers
por: Lee, Tae Won, et al.
Publicado: (2022)

Bioinformatics Analysis of the Prognostic Significance of CAND1 in ERα-Positive Breast Cancer
por: Alhammad, Rashed
Publicado: (2022)

Endoplasmic Reticulum (ER) Stress and Endocrine Disorders
por: Ariyasu, Daisuke, et al.
Publicado: (2017)

ER-positive breast cancer cells are poised for RET-mediated endocrine resistance
por: Horibata, Sachi, et al.
Publicado: (2018)

Rim sign and histogram analysis of apparent diffusion coefficient values on diffusion-weighted MRI in triple-negative breast cancer: Comparison with ER-positive subtype
por: Choi, Yangsean, et al.
Publicado: (2017)

Characterization of Endoplasmic Reticulum (ER) in Human Pluripotent Stem Cells Revealed Increased Susceptibility to Cell Death upon ER Stress
por: Ha, Tae Won, et al.
Publicado: (2020)

Association of oestrogen receptor beta 2 (ERβ2/ERβcx) with outcome of adjuvant endocrine treatment for primary breast cancer – a retrospective study
por: Vinayagam, Raman, et al.
Publicado: (2007)

Modulation of transforming growth factor beta expression and induction of apoptosis by tamoxifen in ER positive and ER negative breast cancer cells.
por: Benson, J. R., et al.
Publicado: (1996)

Expression of ERα, ERβ and Co-Regulator PELP1/MNAR in Colorectal Cancer: Prognostic Significance and Clinicopathologic Correlations
por: Grivas, Petros D., et al.
Publicado: (2009)

The prognostic effects of somatic mutations in ER-positive breast cancer
por: Griffith, Obi L., et al.
Publicado: (2018)

MMP7 expression regulated by endocrine therapy in ERβ-positive colon cancer cells
por: Fang, Yu-Jing, et al.
Publicado: (2009)

Pathologic and biologic response to preoperative endocrine therapy in patients with ER-positive ductal carcinoma in situ
por: Chen, Yunn-Yi, et al.
Publicado: (2009)

Heregulin Drives Endocrine Resistance by Altering IL-8 Expression in ER-Positive Breast Cancer
por: Papadimitropoulou, Adriana, et al.
Publicado: (2020)

AKTIP loss is enriched in ERα-positive breast cancer for tumorigenesis and confers endocrine resistance
por: Ng, Angel S.N., et al.
Publicado: (2022)

Correlation between serum lipid levels and endocrine resistance in patients with ER-positive breast cancer
por: Sun, Hong, et al.
Publicado: (2023)

Neoadjuvant endocrine therapy in ER-positive breast cancer: evolution, indication, and tailored treatment strategy
por: Jeong, Hyehyun, et al.
Publicado: (2023)

Comparison of metabolic changes after neoadjuvant endocrine and chemotherapy in ER-positive, HER2-negative breast cancer
por: Ryu, Ho Hyun, et al.
Publicado: (2021)

Targeting estrogen to kill ER-positive and ER-negative breast cancer
por: Jordan, VC
Publicado: (2005)

EGFR/HER2 inhibitor AEE788 increases ER-mediated transcription in HER2/ER-positive breast cancer cells but functions synergistically with endocrine therapy
por: Evans, A H, et al.
Publicado: (2010)

Aberrant Regulation of RAD51 Promotes Resistance of Neoadjuvant Endocrine Therapy in ER-positive Breast Cancer
por: Jia, Yan, et al.
Publicado: (2019)

PELP-1 regulates adverse responses to endocrine therapy in Estrogen Receptor (ER) positive breast cancer
por: Rees, Michael, et al.
Publicado: (2020)

Circulating tumor cell number and endocrine therapy index in ER positive metastatic breast cancer patients
por: Paoletti, Costanza, et al.
Publicado: (2021)

Functional Significance of Selective Expression of ERα and ERβ in Mammary Gland Organ Culture
por: Mehta, Rajendra G.
Publicado: (2021)

Super-enhancer-controlled positive feedback loop BRD4/ERα–RET–ERα promotes ERα-positive breast cancer
por: Zheng, Zao-zao, et al.
Publicado: (2022)

The interaction between ER and NFκB in resistance to endocrine therapy
por: Sas, Leen, et al.
Publicado: (2012)

Pancreatic beta cell ER export in health and diabetes
por: Barrabi, Cesar, et al.
Publicado: (2023)

An ER-associated miRNA signature predicts prognosis in ER-positive breast cancer
por: Zhou, Xin, et al.
Publicado: (2014)

Detection of estrogen receptors ER-alpha and ER-beta in human ejaculated immature spermatozoa with excess residual cytoplasm
por: Rago, Vittoria, et al.
Publicado: (2006)

ERα/PR crosstalk is altered in the context of the ERα Y537S mutation and contributes to endocrine therapy-resistant tumor proliferation
por: Huggins, Rosemary J., et al.
Publicado: (2023)

MicroRNA-196a is regulated by ER and is a prognostic biomarker in ER+ breast cancer
por: Milevskiy, Michael J. G., et al.
Publicado: (2019)

Immunolocalization of Cytoplasmic ER in ER-negative Breast Carcinoma as a Potent Favorable Prognostic Predictor
por: Ebata, Akiko, et al.
Publicado: (2023)

ER remodeling via ER-phagy
por: Gubas, Andrea, et al.
Publicado: (2022)

A consensus prognostic gene expression classifier for ER positive breast cancer
por: Teschendorff, Andrew E, et al.
Publicado: (2006)

A simple and reproducible prognostic index in luminal ER-positive breast cancers
por: Castellano, I., et al.
Publicado: (2013)

Author Correction: The prognostic effects of somatic mutations in ER-positive breast cancer
por: Griffith, Obi L., et al.
Publicado: (2018)

AGR2 and FOXA1 as prognostic markers in ER-positive breast cancer
por: Zhou, Meng, et al.
Publicado: (2023)

Bioinformatics Identification of TUBB as Potential Prognostic Biomarker for Worse Prognosis in ERα-Positive and Better Prognosis in ERα-Negative Breast Cancer
por: Alhammad, Rashed
Publicado: (2022)

Impact of combining the progesterone receptor and preoperative endocrine prognostic index (PEPI) as a prognostic factor after neoadjuvant endocrine therapy using aromatase inhibitors in postmenopausal ER positive and HER2 negative breast cancer
por: Kurozumi, Sasagu, et al.
Publicado: (2018)

HER2 positivity in patients with estrogen receptor (ER) positive breast cancer: Is it really prognostic?
por: Batra, Atul, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t0e57gj5g0jichipbh2c3hfjqp